{"content":"<li class=\"n-box-item date-title\" data-end=\"1471319999\" data-start=\"1471233600\" data-txt=\"Sunday, December 22, 2019\">Monday, August 15, 2016</li><li class=\"n-box-item sa-box-item\" data-id=\"3203582\" data-ts=\"1471314770\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MBOT\" target=\"_blank\">MBOT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3203582-stemcells-to-be-taken-private-israels-microbot-medical\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">StemCells to be taken private by Israel&#39;s Microbot Medical</a></h4><ul>\n<li>StemCells (STEM) <font color=\"green\">+55.6%</font> AH after disclosing an agreement to <a href=\"https://seekingalpha.com/filing/3194050\" target=\"_blank\">reorganize and merge</a> with privately held Israeli company Microbot Medical.</li>\n<li>Current  STEM shareholders are expected to own 5% of the combined company, while former Microbot stockholders would own 95%.</li>\n<li>Ian Massey has resigned as STEM's CEO, President and as a director, and Gregory Schiffman has resigned as CFO.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3203582\" data-linked=\"StemCells to be taken private by Israel&#39;s Microbot Medical\" data-tweet=\"$MBOT - StemCells to be taken private by Israel&#39;s Microbot Medical https://seekingalpha.com/news/3203582-stemcells-to-be-taken-private-israels-microbot-medical?source=tweet\" data-url=\"https://seekingalpha.com/news/3203582-stemcells-to-be-taken-private-israels-microbot-medical\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>29&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3203578\" data-ts=\"1471303701\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOGO\" target=\"_blank\">GOGO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3203578-gogoplus-4_6-wins-approval-for-chinese-flights\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gogo +4.6% as it wins approval for Chinese flights</a></h4><ul>   <li>Gogo (NASDAQ:<a href=\"https://seekingalpha.com/symbol/GOGO\" title=\"Gogo\">GOGO</a>) <font color=\"green\">gained 4.6%</font> after it announced approval from Chinese regulators to work with its local partner, China Telecom Satellite, to offer in-flight connectivity on flights in and out of China beginning in October.</li>    <li>The move means \"seamless service\" for Gogo-equipped flights heading into China, CEO Michael Small says, and he expects the partners will extend cooperation to Chinese airlines in the future.</li>    <li>One international Gogo partner runs service to China currently, and the company says it has a term sheet with Shareco Technologies to install 2Ku service on 50 aircraft for Shareco partners, including Hainan Airlines and Beijing Capital Airlines.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3203578\" data-linked=\"Gogo +4.6% as it wins approval for Chinese flights\" data-tweet=\"$GOGO - Gogo +4.6% as it wins approval for Chinese flights https://seekingalpha.com/news/3203578-gogoplus-4_6-wins-approval-for-chinese-flights?source=tweet\" data-url=\"https://seekingalpha.com/news/3203578-gogoplus-4_6-wins-approval-for-chinese-flights\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:28 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3203575\" data-ts=\"1471301441\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PX\" target=\"_blank\">PX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3203575-dow-jones-praxair-linde-in-merger-talks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dow Jones: Praxair, Linde in merger talks</a></h4><ul>     <li>Praxair (NYSE:<a href=\"https://seekingalpha.com/symbol/PX\" title=\"Praxair, Inc.\">PX</a>) <font color=\"green\">+3.3%</font> AH following a Dow Jones report that it has <a href=\"http://www.marketwatch.com/story/praxair-linde-said-to-be-discussing-60-billion-merger-2016-08-15\" target=\"_blank\">held merger talks</a> with Germany's Linde (<a href=\"https://seekingalpha.com/symbol/LNAGF\" title=\"Linde AG\">OTCPK:LNAGF</a>), in a deal that would create the world\u2019s largest industrial gas supplier with more than $30B in annual revenue.</li>     <li>The report comes less than <a href=\"https://seekingalpha.com/news/3183206-air-liquide-purchase-airgas-approved-conditions\" target=\"_blank\">three months</a> after Air Liquide bought Airgas for ~$10B, perhaps setting off a wave of consolidation in an industry hit by declining energy prices and sluggish economic growth.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3203575\" data-linked=\"Dow Jones: Praxair, Linde in merger talks\" data-tweet=\"$PX $PX $LNAGF - Dow Jones: Praxair, Linde in merger talks https://seekingalpha.com/news/3203575-dow-jones-praxair-linde-in-merger-talks?source=tweet\" data-url=\"https://seekingalpha.com/news/3203575-dow-jones-praxair-linde-in-merger-talks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:50 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3203574\" data-ts=\"1471301185\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TEUM\" target=\"_blank\">TEUM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3203574-elephant-talk-restructures-key-loan\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Elephant Talk restructures key loan</a></h4><ul>   <li>Under a cash crunch, Elephant Talk Communications (<a href=\"https://seekingalpha.com/symbol/ETAK\" target=\"_blank\">ETAK</a> <font color=\"green\">+3.6%</font>) has come to terms with its senior lender on restructuring its existing $6M loan.</li>    <li>The new deal waives existing defaults, increases the loan facility by just over $1.2M, and resets the maturity date to this Dec. 31.</li>    <li>The company has been pursuing a new approach since <a href=\"https://seekingalpha.com/news/2582335-elephant-talk-up-11_8-percent-on-iusacell-settlement\" target=\"_blank\">losing Iusacell</a>, its second-largest customer, to its takeover by AT&amp;T.</li>    <li>It took the opportunity to highlight its strategic partnership with Vodafone Enabler, supportive of Elephant Talk \"throughout the recent financial difficulties.\"</li>    <li>\"Already this last year, we grew our subscriber base on the ET platform by 9%, and with our new joint strategic initiatives we are looking to grow from 1.2M active subscribers to 1.6M subscribers in the next fiscal year,\" says Vodafone Enabler CEO Luis Jiménez-Tuñón.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3203574\" data-linked=\"Elephant Talk restructures key loan\" data-tweet=\"$TEUM - Elephant Talk restructures key loan https://seekingalpha.com/news/3203574-elephant-talk-restructures-key-loan?source=tweet\" data-url=\"https://seekingalpha.com/news/3203574-elephant-talk-restructures-key-loan\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:46 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3203551\" data-ts=\"1471296882\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3203551-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li><b>Top gainers, as of 5.25 p.m.:</b> <a href='https://seekingalpha.com/symbol/PNK' title='Pinnacle Entertainment, Inc.'>PNK</a> <font color='green'>+4.8%</font>. <a href='https://seekingalpha.com/symbol/PETX' title='Aratana Therapeutics'>PETX</a> <font color='green'>+4.1%</font>. <a href='https://seekingalpha.com/symbol/FN' title='Fabrinet'>FN</a> <font color='green'>+4.0%</font>. <a href='https://seekingalpha.com/symbol/HDP' title='Hortonworks'>HDP</a> <font color='green'>+3.5%</font>. <a href='https://seekingalpha.com/symbol/VIPS' title='Vipshop Holdings'>VIPS</a> <font color='green'>+3.2%</font>.</li><li><b>Top losers, as of 5.25p.m.:</b> <a href='https://seekingalpha.com/symbol/HAIN' title='The Hain Celestial Group, Inc.'>HAIN</a> <font color='red'>-24.6%</font>. <a href='https://seekingalpha.com/symbol/VRTX' title='Vertex Pharmaceuticals Incorporated'>VRTX</a> <font color='red'>-3.2%</font>. <a href='https://seekingalpha.com/symbol/DAVE' title='Famous Dave&#39;s of America, Inc.'>DAVE</a> <font color='red'>-3.1%</font>. <a href='https://seekingalpha.com/symbol/COWN' title='Cowen Group, Inc.'>COWN</a> <font color='red'>-3.0%</font>. <a href='https://seekingalpha.com/symbol/SHOP' title='Shopify'>SHOP</a> <font color='red'>-3.0%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3203551\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$PNK $PETX $FN - After Hours Gainers / Losers https://seekingalpha.com/news/3203551-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3203551-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:34 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3203550\" data-ts=\"1471296748\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HAIN\" target=\"_blank\">HAIN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3203550-hain-celestial-to-delay-q4-fy-2016-results-evaluating-internal-controls\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hain Celestial to delay Q4, FY 2016 results; evaluating internal controls</a></h4><ul>     <li>Hain Celestial (NASDAQ:<a href=\"https://seekingalpha.com/symbol/HAIN\" title=\"The Hain Celestial Group, Inc.\">HAIN</a>) <font color=\"red\">-23.7%</font> AH after saying it is delaying the release of its Q4 and FY 2016 financial results, and that it does not expect to achieve its previously announced full-year guidance.</li>     <li>Hain says it identified concessions that were granted to certain  distributors, and is evaluating whether associated revenue was accounted for in the correct  period, and is evaluating its internal control over  financial reporting.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3203550\" data-linked=\"Hain Celestial to delay Q4, FY 2016 results; evaluating internal controls\" data-tweet=\"$HAIN - Hain Celestial to delay Q4, FY 2016 results; evaluating internal controls https://seekingalpha.com/news/3203550-hain-celestial-to-delay-q4-fy-2016-results-evaluating-internal-controls?source=tweet\" data-url=\"https://seekingalpha.com/news/3203550-hain-celestial-to-delay-q4-fy-2016-results-evaluating-internal-controls\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>36&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3203501\" data-ts=\"1471293971\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VRTX\" target=\"_blank\">VRTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3203501-vertex-dumps-clinical-development-of-cf-candidate-vxminus-661-for-cf-patients-minimal-cftr\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vertex dumps clinical development of CF candidate VX-661 for CF patients with minimal CFTR protein function; shares slump 3% after hours</a></h4><ul>\n<li>Vertex Pharmaceuticals (NASDAQ:<a href=\"https://seekingalpha.com/symbol/VRTX\" title=\"Vertex Pharmaceuticals Incorporated\">VRTX</a>) is down <font color=\"red\">3%</font> after hours on increased volume in response to its <a href=\"http://www.businesswire.com/news/home/20160815006099/en/Vertex-Update-Ongoing-Phase-3-Program-VX-661\" target=\"_blank\">announcement </a>that it has terminated clinical development of lead <a href=\"http://www.vrtx.com/research-development/pipeline\" target=\"_blank\">pipeline </a>candidate VX-661, in combination with <a href=\"http://www.kalydeco.com/\" target=\"_blank\">Kalydeco </a>(ivacaftor), for the treatment of cystic fibrosis (CF) patients with only one copy of the F508del mutation and one copy of a mutation that results in minimal CFTR protein function (F508del het/min). Its decision was based on the results from a planned interim futility analysis by the independent Data Safety Monitoring Board that showed an insufficient improvement in lung function in these difficult-to-treat patients.</li>\n<li>The company believes a triple combination of a next-generation CFTR corrector + VX-661 + ivacaftor may have potential in this population. A clinical trial is on tap for later this year after Phase 1 data in healthy volunteers is collected.</li>\n<li>The clinical development of VX-661 will continue in three populations of CF patients: those with two copies of the F508del mutation, those with one copy of the F508del mutation and a second mutation that results in residual CFTR function and those with one copy of the F508del mutation and a second mutation that results in a gating defect in the CFTR protein.</li>\n<li>The company says it still expects to file a New Drug Application (NDA) with the FDA seeking approval of VX-661, in combination with ivacaftor, in H2 2017. The filing will include data from the study in patients with minimal CFTR function mutations.</li>\n<li>VX-661 is CF transmembrane conductance regulator (CFTR) corrector. CF is caused by loss-of-function mutations in the CFTR protein. A CFTR corrector addresses the defects in the cellular processing and chloride channel function of CF-causing mutant CFTR alleles, thereby producing a clinical benefit.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3203501\" data-linked=\"Vertex dumps clinical development of CF candidate VX-661 for CF patients with minimal CFTR protein function; shares slump 3% after hours\" data-tweet=\"$VRTX - Vertex dumps clinical development of CF candidate VX-661 for CF patients with minimal CFTR protein function; shares slump 3% after hours https://seekingalpha.com/news/3203501-vertex-dumps-clinical-development-of-cf-candidate-vxminus-661-for-cf-patients-minimal-cftr?source=tweet\" data-url=\"https://seekingalpha.com/news/3203501-vertex-dumps-clinical-development-of-cf-candidate-vxminus-661-for-cf-patients-minimal-cftr\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:46 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3203483\" data-ts=\"1471293219\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EVOK\" target=\"_blank\">EVOK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3203483-evoke-pharma-beats-0_02\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Evoke Pharma beats by $0.02</a></h4><ul>\n<li>Evoke Pharma (NASDAQ:<a href=\"https://seekingalpha.com/symbol/EVOK\" title=\"Evoke Pharma, Inc.\">EVOK</a>): Q2 EPS of -$0.41 <font color=\"green\">beats by $0.02</font>.</li>\n<li>Cash and cash equivalents of $4.1M.</li>\n<li>Shares <font color=\"red\">-11.9%</font> AH.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3203483\" data-linked=\"Evoke Pharma beats by $0.02\" data-tweet=\"$EVOK - Evoke Pharma beats by $0.02 https://seekingalpha.com/news/3203483-evoke-pharma-beats-0_02?source=tweet\" data-url=\"https://seekingalpha.com/news/3203483-evoke-pharma-beats-0_02\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:33 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3203481\" data-ts=\"1471293179\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VIPS\" target=\"_blank\">VIPS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3203481-vipshop-holdingsplus-4-in-extended-trading-on-q2-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vipshop Holdings +4% in extended trading on Q2 report</a></h4><ul>\n<li>Vipshop (NYSE:<a href=\"https://seekingalpha.com/symbol/VIPS\" title=\"Vipshop Holdings\">VIPS</a>) realized a 49% Y/Y total net revenue ($2.02B) increase, a 62% Y/Y active customer (23M) increase and 54% Y/Y total order (68.9M) increase.</li>\n<li>Gross profit grew 44% Y/Y to $487.7M and income from operations grew 47.2% Y/Y to $126M.</li>\n<li>Cites focus on diversifying product offerings and enhancing logistics capabilities.</li>\n<li>Projects Q3 total net revenue of $1.79B-$1.87B (37%-43% Y/Y growth).</li>\n<li><a href=\"https://seekingalpha.com/news/3203444-vipshop-holdings-beats-0_02-beats-revenue\" target=\"_blank\">Results</a></li>\n<li><a href=\"http://edge.media-server.com/m/p/cp5p723f/lan/en\" target=\"_blank\">Conference call</a></li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3203481\" data-linked=\"Vipshop Holdings +4% in extended trading on Q2 report\" data-tweet=\"$VIPS - Vipshop Holdings +4% in extended trading on Q2 report https://seekingalpha.com/news/3203481-vipshop-holdingsplus-4-in-extended-trading-on-q2-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3203481-vipshop-holdingsplus-4-in-extended-trading-on-q2-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:32 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3203464\" data-ts=\"1471292513\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FN\" target=\"_blank\">FN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3203464-fabrinet-eps-in-line-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fabrinet EPS in-line, beats on revenue</a></h4><ul>\n<li>Fabrinet (NYSE:<a href=\"https://seekingalpha.com/symbol/FN\" title=\"Fabrinet\">FN</a>): FQ4 EPS of $0.60 in-line.</li>\n<li>Revenue of $276.4M (+33.9% Y/Y) <font color=\"green\">beats by $13.45M</font>.</li>\n<li>Shares <font color=\"green\">+4.9%</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3203464\" data-linked=\"Fabrinet EPS in-line, beats on revenue\" data-tweet=\"$FN - Fabrinet EPS in-line, beats on revenue https://seekingalpha.com/news/3203464-fabrinet-eps-in-line-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3203464-fabrinet-eps-in-line-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3203444\" data-ts=\"1471291599\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VIPS\" target=\"_blank\">VIPS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3203444-vipshop-holdings-beats-0_02-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vipshop Holdings beats by $0.02, beats on revenue</a></h4><ul>\n<li>Vipshop Holdings (NYSE:<a href=\"https://seekingalpha.com/symbol/VIPS\" title=\"Vipshop Holdings\">VIPS</a>): Q2 EPS of $0.17 <font color=\"green\">beats by $0.02</font>.</li>\n<li>Revenue of $2.02B (+39.3% Y/Y) <font color=\"green\">beats by $120M</font>.</li>\n<li>Shares <font color=\"green\">+3%</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3203444\" data-linked=\"Vipshop Holdings beats by $0.02, beats on revenue\" data-tweet=\"$VIPS - Vipshop Holdings beats by $0.02, beats on revenue https://seekingalpha.com/news/3203444-vipshop-holdings-beats-0_02-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3203444-vipshop-holdings-beats-0_02-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3203435\" data-ts=\"1471291422\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EAC\" target=\"_blank\">EAC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3203435-erickson-air-crane-misses-2_17-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Erickson Air-Crane misses by $2.17, misses on revenue</a></h4><ul>\n<li>Erickson Air-Crane (NASDAQ:<a href=\"https://seekingalpha.com/symbol/EAC\" title=\"Erickson Air-Crane\">EAC</a>): Q2 EPS of -$2.81 <font color=\"red\">misses by $2.17</font>.</li>\n<li>Revenue of $50.8M (-24.2% Y/Y) <font color=\"red\">misses by $4.2M</font>.</li>\n<li>Shares <font color=\"green\">+3.3%</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3203435\" data-linked=\"Erickson Air-Crane misses by $2.17, misses on revenue\" data-tweet=\"$EAC - Erickson Air-Crane misses by $2.17, misses on revenue https://seekingalpha.com/news/3203435-erickson-air-crane-misses-2_17-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3203435-erickson-air-crane-misses-2_17-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:03 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3203415\" data-ts=\"1471287607\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3203415-technology-top-5-gainers-losers-of-3-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top 5 Gainers / Losers as of 3:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/TWLO' title='Twilio'>TWLO</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/NEON' title='Neonode, Inc.'>NEON</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/CRNT' title='Ceragon Networks Ltd.'>CRNT</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/EGAN' title='eGain Communications Corp.'>EGAN</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/INVN' title='InvenSense'>INVN</a> <font color='green'>+10%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/MEET' title='The Meet Group, Inc.'>MEET</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/MXPT' title='MaxPoint Interactive'>MXPT</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/LEDS' title='SemiLEDs Corporation'>LEDS</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/DYSL' title='Dynasil Corporation of America'>DYSL</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/NIHD' title='NII Holdings, Inc.'>NIHD</a> <font color='red'>-6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3203415\" data-linked=\"Technology - Top 5 Gainers / Losers as of 3:00 pm\" data-tweet=\"$TWLO $NEON $CRNT - Technology - Top 5 Gainers / Losers as of 3:00 pm https://seekingalpha.com/news/3203415-technology-top-5-gainers-losers-of-3-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3203415-technology-top-5-gainers-losers-of-3-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3203409\" data-ts=\"1471287074\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HSGX\" target=\"_blank\">HSGX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3203409-histogenics-up-on-continued-progress-of-pivotal-study-of-neocart\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Histogenics up on continued progress of pivotal study of NeoCart</a></h4><ul>\n<li>Thinly traded nano cap Histogenics (<a href=\"https://seekingalpha.com/symbol/HSGX\" title=\"Histogenics Corporation\">HSGX</a> <font color=\"green\">+31.1%</font>) heads north on almost quadruple normal volume, albeit on turnover of only 84K shares, in response to the news that it increased the low end of its 2016 patient recruitment range for its Phase 3 study assessing lead product candidate NeoCart. It now expects to have enrolled 190 - 200 patients by year end, up from at least 180. It expects to hit its enrollment target of 245 subjects by end of Q2 2017.</li>\n<li>\n<a href=\"http://www.histogenics.com/products-platform/neocart\" target=\"_blank\">NeoCart </a>is an autologous cartilage implant for the repair of cartilage damage in the knee.</li>\n<li>Adding a bit of spice to the buying was an upgrade to Buy from Neutral by BTIG Research on Friday citing improved prospects for NeoCart. The price target is $3.50 (33% upside).</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3203409\" data-linked=\"Histogenics up on continued progress of pivotal study of NeoCart\" data-tweet=\"$HSGX $OCGN - Histogenics up on continued progress of pivotal study of NeoCart https://seekingalpha.com/news/3203409-histogenics-up-on-continued-progress-of-pivotal-study-of-neocart?source=tweet\" data-url=\"https://seekingalpha.com/news/3203409-histogenics-up-on-continued-progress-of-pivotal-study-of-neocart\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:51 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3203410\" data-ts=\"1471286673\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MCD\" target=\"_blank\">MCD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3203410-eating-home-trend-prompts-caution-from-argus-on-mcdonalds\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Eating at home trend prompts caution from Argus on McDonald&#39;s</a></h4><ul> <li>Argus downshifts on McDonald's (<a href=\"https://seekingalpha.com/symbol/MCD\" title=\"McDonald's Corporation\">MCD</a> <font color=\"red\">-0.6%</font>) on concerns over comparable store sales growth and rising wages.</li> <li>While the added pressure of higher wages isn't completely unexpected, the <a href=\"https://seekingalpha.com/news/3202693-wendys-ceo-points-high-cost-eating-traffic-drag\" target=\"_blank\">recent trend</a> highlighted by Wendy's CEO Todd Penegor and others of consumer pushback on pricing amid cheaper at home options is creating a ripple of worry in the sector.</li> <li>The investment firm lowers its rating on the McDonald's to Hold from Buy.</li>\n<li>Shares of McDonald's haven't been able to break through the $120 level this month.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3203410\" data-linked=\"Eating at home trend prompts caution from Argus on McDonald&#39;s\" data-tweet=\"$MCD - Eating at home trend prompts caution from Argus on McDonald&#39;s https://seekingalpha.com/news/3203410-eating-home-trend-prompts-caution-from-argus-on-mcdonalds?source=tweet\" data-url=\"https://seekingalpha.com/news/3203410-eating-home-trend-prompts-caution-from-argus-on-mcdonalds\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3203413\" data-ts=\"1471286190\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SM\" target=\"_blank\">SM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3203413-sm-energy-rallies-on-piper-jaffray-upgrade-higher-oil-prices\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SM Energy rallies on Piper Jaffray upgrade, higher oil prices</a></h4><ul>     <li>SM Energy (<a href=\"https://seekingalpha.com/symbol/SM\" title=\"SM Energy Company\">SM</a> <font color=\"green\">+6.4%</font>) shoots higher after Piper Jaffray <a href=\"https://www.thestreet.com/story/13674963/1/sm-energy-sm-stock-climbs-on-upgrade-higher-oil-prices.html\" target=\"_blank\">upgrades</a> shares to Overweight from Neutral with a $42 price target, raised from $38, citing an attractive valuation and the company's \"transformational\" Permian Basin acquisition.</li>     <li>\n<a href=\"https://seekingalpha.com/news/3200980-sm-energy-acquire-midland-basin-acreage-980m\" target=\"_blank\">Last week</a>, SM bought 24,783 net acres in Howard County, Tex., expanding its Midland Basin footprint to 46,750 net acres.</li>\n<li>Shares also are helped as crude oil futures prices rise on hopes that major producers may agree to freeze output next month.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3203413\" data-linked=\"SM Energy rallies on Piper Jaffray upgrade, higher oil prices\" data-tweet=\"$SM - SM Energy rallies on Piper Jaffray upgrade, higher oil prices https://seekingalpha.com/news/3203413-sm-energy-rallies-on-piper-jaffray-upgrade-higher-oil-prices?source=tweet\" data-url=\"https://seekingalpha.com/news/3203413-sm-energy-rallies-on-piper-jaffray-upgrade-higher-oil-prices\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:36 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3203576\" data-ts=\"1471285647\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/REN\" target=\"_blank\">REN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3203576-resolute-energy-raises-2016-production-guidance-plans-drilling-in-2017\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Resolute Energy raises 2016 production guidance, plans more drilling in 2017</a></h4><ul>     <li>Resolute Energy (<a href=\"https://seekingalpha.com/symbol/REN\" title=\"Resolute Energy Corporation\">REN</a> <font color=\"green\">+12.2%</font>) rockets higher after <a href=\"http://www.resoluteenergy.com/downloads/IR%20Presentation%20August%202016.pdf\" target=\"_blank\">raising its FY 2016 production guidance</a> and outlining plans to increase drilling in 2017, in a presentation at the EnerCom Oil &amp; Gas Conference.</li>\n<li>REN says it increases 2016 production guidance to 11.6K-13.4K boe/day from its prior outlook for 10.2K-11.9K boe/day, and plans to increase drilling activity next year with a potential two-rig, 20-plus well program; REN notes that one rig in 2017 and two rigs in 2018 would nearly double company production in two years.</li>\n<li>REN also reaffirms its 2016 capex guidance at $115M-$135M.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3203576\" data-linked=\"Resolute Energy raises 2016 production guidance, plans more drilling in 2017\" data-tweet=\"$REN - Resolute Energy raises 2016 production guidance, plans more drilling in 2017 https://seekingalpha.com/news/3203576-resolute-energy-raises-2016-production-guidance-plans-drilling-in-2017?source=tweet\" data-url=\"https://seekingalpha.com/news/3203576-resolute-energy-raises-2016-production-guidance-plans-drilling-in-2017\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:27 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3203407\" data-ts=\"1471284618\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TWLO\" target=\"_blank\">TWLO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3203407-twilio-trading-318-above-ipo-price\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Twilio trading 318% above IPO price</a></h4><ul>\n<li>Twilio (<a href=\"https://seekingalpha.com/symbol/TWLO\" title=\"Twilio\">TWLO</a> <font color=\"green\">+15.7%</font>) continues to extend <a href=\"https://seekingalpha.com/news/3202686-twilio-tear-since-reporting-first-post-ipo-results-70-percent-revenue-growth\" target=\"_blank\">sharp gains</a>, trading at three times the usual share volume (12.48M vs. 4.19M).</li>\n<li>The company is now <font color=\"green\">up over 45%</font> since <a href=\"https://seekingalpha.com/news/3201190-twilio-posts-70-percent-revenue-growth-first-post-ipo-earnings-report\" target=\"_blank\">posting</a> 70% revenue growth in its Q2 report and <font color=\"green\">up more than 110%</font> from opening-day trading levels.</li>\n<li>Twilio is smashing <a href=\"https://seekingalpha.com/news/3193781-twilio-quiet-period-expires-analysts-check-subdued-ratings\" target=\"_blank\">analyst price targets</a> that were set at the end of the mandated 25-day quiet period following the offering.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3203407\" data-linked=\"Twilio trading 318% above IPO price\" data-tweet=\"$TWLO - Twilio trading 318% above IPO price https://seekingalpha.com/news/3203407-twilio-trading-318-above-ipo-price?source=tweet\" data-url=\"https://seekingalpha.com/news/3203407-twilio-trading-318-above-ipo-price\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>23&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3203406\" data-ts=\"1471284323\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EXPE\" target=\"_blank\">EXPE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3203406-jana-partners-picks-up-expe-bery-and-cce-and-trims-cag\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Jana Partners picks up EXPE, BERY, and CCE and trims CAG</a></h4><ul> <li>Jana Partners discloses that it acquired over 2.069M shares of Expedia (<a href='https://seekingalpha.com/symbol/EXPE' title='Expedia, Inc.'>EXPE</a> <font color='green'>+0.9%</font>).</li> <li>Other new positions include Berry Plastics Group (<a href='https://seekingalpha.com/symbol/BERY' title='Berry Plastics Group, Inc.'>BERY</a> <font color='green'>+1.7%</font>) and Coca-Cola European Partners (<a href='https://seekingalpha.com/symbol/CCE-OLD' title='Coca-Cola European Partners plc'>CCE-OLD</a> <font color='green'>+0.6%</font>).</li><li>The hedge fund trimmed its holdings in ConAgra (<a href='https://seekingalpha.com/symbol/CAG' title='ConAgra Brands, Inc.'>CAG</a> <font color='red'>-0.6%</font>) to 18.036M shares</li> <li><a href=\"https://www.sec.gov/Archives/edgar/data/1159159/000090266416007861/xslForm13F_X01/infotable.xml\" target=\"_blank\">SEC Form 13F</a></li>  </ul><div class=\"tiny-share-widget\" data-id=\"3203406\" data-linked=\"Jana Partners picks up EXPE, BERY, and CCE and trims CAG\" data-tweet=\"$EXPE $EXPE $BERY - Jana Partners picks up EXPE, BERY, and CCE and trims CAG https://seekingalpha.com/news/3203406-jana-partners-picks-up-expe-bery-and-cce-and-trims-cag?source=tweet\" data-url=\"https://seekingalpha.com/news/3203406-jana-partners-picks-up-expe-bery-and-cce-and-trims-cag\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:05 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3203405\" data-ts=\"1471284141\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3203405-energy-materials-top-5-gainers-losers-of-2-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top 5 Gainers / Losers as of 2:00 pm</a></h4><ul> <li>\n<b>Gainers:</b> <a href=\"https://seekingalpha.com/symbol/SIM\" title=\"Grupo Simec S.A.B. de C.V.\">SIM</a> <font color=\"green\">+21%</font>. <a href=\"https://seekingalpha.com/symbol/REN\" title=\"Resolute Energy Corporation\">REN</a> <font color=\"green\">+13%</font>. BBG <font color=\"green\">+12%</font>. <a href=\"https://seekingalpha.com/symbol/SAEX\" title=\"SAExploration Holdings, Inc.\">SAEX</a> <font color=\"green\">+12%</font>. <a href=\"https://seekingalpha.com/symbol/DNR\" title=\"Denbury Resources Inc.\">DNR</a> <font color=\"green\">+10%</font>.</li> <li>\n<b>Losers:</b> <a href=\"https://seekingalpha.com/symbol/TRCH\" title=\"Torchlight Energy Resources, Inc.\">TRCH</a> <font color=\"red\">-9%</font>. <a href=\"https://seekingalpha.com/symbol/SDPI\" title=\"Superior Drilling Products, Inc.\">SDPI</a> <font color=\"red\">-8%</font>. MPET <font color=\"red\">-8%</font>. <a href=\"https://seekingalpha.com/symbol/DELT\" title=\"Delta Technology Holdings Limited\">DELT</a> <font color=\"red\">-7%</font>. <a href=\"https://seekingalpha.com/symbol/CELP\" title=\"Cypress Energy Partners, L.P.\">CELP</a> <font color=\"red\">-6%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3203405\" data-linked=\"Energy/Materials - Top 5 Gainers / Losers as of 2:00 pm\" data-tweet=\"$SIM $REN $HPR - Energy/Materials - Top 5 Gainers / Losers as of 2:00 pm https://seekingalpha.com/news/3203405-energy-materials-top-5-gainers-losers-of-2-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3203405-energy-materials-top-5-gainers-losers-of-2-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3203402\" data-ts=\"1471282777\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FLL\" target=\"_blank\">FLL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3203402-full-house-resorts-announces-rights-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Full House Resorts announces rights offering</a></h4><ul> <li>Full House Resorts (<a href=\"https://seekingalpha.com/symbol/FLL\" title=\"Full House Resorts, Inc\">FLL</a> <font color=\"red\">-7.4%</font>) files for a proposed $5M rights offering.</li>\n<li>The company expects to distribute subscription rights to purchase shares of its  common stock for $1.30 per share.</li>\n<li>The subscription rights will be exercisable for up to a total of 3.846154M shares.</li>  <li>The company says the total gross proceeds of the proposed rights offering is \"highly likely\" to be $5M whether or not fully subscribed by the rightsholders because it's entering into a standby purchaser agreement with CEO Daniel Lee. </li>  <li>Full House indicates that the purpose of the proposed rights offering is to raise equity capital in a cost-effective manner that allows current holders of common stock to participate.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3203402\" data-linked=\"Full House Resorts announces rights offering\" data-tweet=\"$FLL - Full House Resorts announces rights offering https://seekingalpha.com/news/3203402-full-house-resorts-announces-rights-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3203402-full-house-resorts-announces-rights-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:39 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3203398\" data-ts=\"1471281654\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3203398-financials-top-5-gainers-losers-of-1-20-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:20 PM</a></h4><ul>\n<li>\n<b>Gainers:</b> <a href=\"https://seekingalpha.com/symbol/YRD\" title=\"Yirendai LTD.\">YRD</a> <font color=\"green\">+17%</font>. <a href=\"https://seekingalpha.com/symbol/PPS\" title=\"Post Properties Inc.\">PPS</a> <font color=\"green\">+9%</font>. <a href=\"https://seekingalpha.com/symbol/LC\" title=\"LendingClub Corporation\">LC</a> <font color=\"green\">+7%</font>. <a href=\"https://seekingalpha.com/symbol/EZPW\" title=\"EZCORP, Inc.\">EZPW</a> <font color=\"green\">+6%</font>. <a href=\"https://seekingalpha.com/symbol/GRBK\" title=\"Green Brick Partners, Inc\">GRBK</a> <font color=\"green\">+6%</font>.</li>\n<li>\n<b>Losers:</b> <a href=\"https://seekingalpha.com/symbol/FNBC\" title=\"First NBC Bank Holding Company\">OTC:FNBC</a> <font color=\"red\">-9%</font>. <a href=\"https://seekingalpha.com/symbol/ZAIS\" title=\"ZAIS Group Holdings\">ZAIS</a> <font color=\"red\">-7%</font>. CRD-B <font color=\"red\">-6%</font>. <a href=\"https://seekingalpha.com/symbol/MAA\" title=\"Mid-America Apartment Communities Inc.\">MAA</a> <font color=\"red\">-5%</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3203398\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:20 PM\" data-tweet=\"$YRD $PPS $LC - Financials - Top 5 Gainers / Losers as of 1:20 PM https://seekingalpha.com/news/3203398-financials-top-5-gainers-losers-of-1-20-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3203398-financials-top-5-gainers-losers-of-1-20-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3203397\" data-ts=\"1471280763\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSLA\" target=\"_blank\">TSLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3203397-report-tesla-model-s-promotional-drive-ends-in-flames\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Report: Tesla Model S promotional drive ends in flames</a></h4><ul> <li>A Tesla Model S 90D erupted into flames during a drive in France that was part of the company's global <a href=\"https://www.tesla.com/electricroadtrip\" target=\"_blank\">Electric Road Trip promotion</a>.</li> <li>Electrek <a href=\"https://electrek.co/2016/08/15/tesla-model-s-catches-fire-test-drive-france/\" target=\"_blank\">reports</a> that a loud noise and a visual charging alert on the dashboard gave the passengers in the vehicle enough time to exit the vehicle before the fire started.</li> <li>The exact cause of the fire is unknown at the moment.</li>\n<li>Shares of Tesla Motors (NASDAQ:<a href=\"https://seekingalpha.com/symbol/TSLA\" title=\"Tesla, Inc.\">TSLA</a>) are <font color=\"green\">up 0.41%</font> to $226.54.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3203397\" data-linked=\"Report: Tesla Model S promotional drive ends in flames\" data-tweet=\"$TSLA - Report: Tesla Model S promotional drive ends in flames https://seekingalpha.com/news/3203397-report-tesla-model-s-promotional-drive-ends-in-flames?source=tweet\" data-url=\"https://seekingalpha.com/news/3203397-report-tesla-model-s-promotional-drive-ends-in-flames\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>192&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3203392\" data-ts=\"1471280081\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3203392-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers /Losers</a></h4><ul>     <li>\n<b>Gainers:</b> <a href=\"https://seekingalpha.com/symbol/SORL\" title=\"SORL Auto Parts, Inc.\">SORL</a> <font color=\"green\">+51%</font>. <a href=\"https://seekingalpha.com/symbol/PWX\" title=\"Providence and Worcester Railroad Company\">PWX</a> <font color=\"green\">+51%</font>. <a href=\"https://seekingalpha.com/symbol/AETI\" title=\"American Electric Technologies, Inc.\">AETI</a> <font color=\"green\">+48%</font>. <a href=\"https://seekingalpha.com/symbol/OBCI\" title=\"Ocean Bio-Chem, Inc.\">OBCI</a> <font color=\"green\">+31%</font>. <a href=\"https://seekingalpha.com/symbol/HSGX\" title=\"Histogenics Corporation\">HSGX</a> <font color=\"green\">+30%</font>. <a href=\"https://seekingalpha.com/symbol/SVT\" title=\"Servotronics, Inc\">SVT</a> <font color=\"green\">+21%</font>. <a href=\"https://seekingalpha.com/symbol/SMLR\" title=\"Semler Scientific Inc\">OTC:SMLR</a> <font color=\"green\">+20%</font>. <a href=\"https://seekingalpha.com/symbol/LNTH\" title=\"Lantheus Holdings\">LNTH</a> <font color=\"green\">+19%</font>. <a href=\"https://seekingalpha.com/symbol/SIM\" title=\"Grupo Simec S.A.B. de C.V.\">SIM</a> <font color=\"green\">+18%</font>. EBIO <font color=\"green\">+17%</font>.</li>\n<li>\n<b>Losers:</b> <a href=\"https://seekingalpha.com/symbol/AUPH\" title=\"Aurinia Pharmaceuticals Inc.\">AUPH</a> <font color=\"red\">-55%</font>. <a href=\"https://seekingalpha.com/symbol/PSG\" title=\"Performance Sports Group Ltd.\">PSG</a> <font color=\"red\">-53%</font>. <a href=\"https://seekingalpha.com/symbol/MSLI\" title=\"Merus Labs International, Inc.\">MSLI</a> <font color=\"red\">-23%</font>. CLNT <font color=\"red\">-15%</font>. <a href=\"https://seekingalpha.com/symbol/ESEA\" title=\"Euroseas Ltd.\">ESEA</a> <font color=\"red\">-13%</font>. <a href=\"https://seekingalpha.com/symbol/MXPT\" title=\"MaxPoint Interactive\">MXPT</a> <font color=\"red\">-13%</font>. <a href=\"https://seekingalpha.com/symbol/MEET\" title=\"The Meet Group, Inc.\">MEET</a> <font color=\"red\">-12%</font>. <a href=\"https://seekingalpha.com/symbol/LBIX-OLD\" title=\"Leading Brands Inc\">LBIX-OLD</a> <font color=\"red\">-12%</font>. <a href=\"https://seekingalpha.com/symbol/DVCR\" title=\"Diversicare Healthcare Services Inc.\">DVCR</a> <font color=\"red\">-12%</font>. <a href=\"https://seekingalpha.com/symbol/FNBC\" title=\"First NBC Bank Holding Company\">OTC:FNBC</a> <font color=\"red\">-9%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3203392\" data-linked=\"Midday Gainers /Losers\" data-tweet=\"$SORL $PWX $SLNG - Midday Gainers /Losers https://seekingalpha.com/news/3203392-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3203392-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:54 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3203391\" data-ts=\"1471280079\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SBGI\" target=\"_blank\">SBGI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3203391-sinclair-broadcast-group-rolling-over-350m-in-notes\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sinclair Broadcast Group rolling over $350M in notes</a></h4><ul>   <li>Sinclair Broadcast Group (<a href=\"https://seekingalpha.com/symbol/SBGI\" title=\"Sinclair Broadcast Group, Inc.\">SBGI</a> <font color=\"green\">+2.6%</font>) has set a private offering of $350M in senior debt, set to roll over notes due in 2021.</li>    <li>The company is offering that amount in senior unsecured notes due to mature in 2027. It plans to use proceeds to redeem its Sinclair Television Group unit's $350M in 6.375% notes due 2021, with a redemption date planned for Aug. 30.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3203391\" data-linked=\"Sinclair Broadcast Group rolling over $350M in notes\" data-tweet=\"$SBGI - Sinclair Broadcast Group rolling over $350M in notes https://seekingalpha.com/news/3203391-sinclair-broadcast-group-rolling-over-350m-in-notes?source=tweet\" data-url=\"https://seekingalpha.com/news/3203391-sinclair-broadcast-group-rolling-over-350m-in-notes\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:54 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3203388\" data-ts=\"1471278765\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MSLI\" target=\"_blank\">MSLI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3203388-merus-fiscal-q3-top-line-up-171-non-gaap-ebitda-up-88-lower-guidance-sinks-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Merus fiscal Q3 top line up 171%, non-GAAP EBITDA up 88%, lower guidance sinks shares</a></h4><ul><li>Thinly traded micro cap Merus Labs International (<a href=\"https://seekingalpha.com/symbol/MSLI\" title=\"Merus Labs International, Inc.\">MSLI</a> <font color=\"red\">-22.6%</font>) slumps on a 12x surge in volume, albeit on turnover of only 129K shares, in response to its fiscal Q3 results released this morning. Sales and adjusted EBITDA were up nicely, but the company lowered its 2016 guidance for non-GAAP EBITDA to $43M - 46M from $47M - 50M citing higher-than-planned expenses.</li></ul><div class=\"tiny-share-widget\" data-id=\"3203388\" data-linked=\"Merus fiscal Q3 top line up 171%, non-GAAP EBITDA up 88%, lower guidance sinks shares\" data-tweet=\"$MSLI - Merus fiscal Q3 top line up 171%, non-GAAP EBITDA up 88%, lower guidance sinks shares https://seekingalpha.com/news/3203388-merus-fiscal-q3-top-line-up-171-non-gaap-ebitda-up-88-lower-guidance-sinks-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3203388-merus-fiscal-q3-top-line-up-171-non-gaap-ebitda-up-88-lower-guidance-sinks-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:32 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3203387\" data-ts=\"1471278506\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HP\" target=\"_blank\">HP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3203387-helmerich-payne-reiterated-buy-argus-better-positioned-peers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Helmerich &amp; Payne reiterated Buy at Argus as better positioned than peers</a></h4><ul>     <li>Helmerich &amp; Payne (<a href=\"https://seekingalpha.com/symbol/HP\" title=\"Helmerich &amp; Payne Inc.\">HP</a> <font color=\"green\">+2.2%</font>) is better positioned that its oil and gas drilling peers in a challenging environment, Argus says as it <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/16/08/8350429/in-a-challenging-environment-argus-sees-helmerich-payne-\" target=\"_blank\">maintains a Buy rating</a> and $72 price target on the company.</li>     <li>The firm cites HP's industry-low debt, which offers the flexibility to add debt without straining its balance sheet, and the company\u2019s above-peer-average dividend yield of 4.5%.</li>     <li>Argus notes that HP's <a href=\"https://seekingalpha.com/news/3196930-helmerich-and-payne-eps-0_83\" target=\"_blank\">Q2 operating loss</a> primarily was due to lower drilling revenue, driven by reduced capital spending as well as lower drill margins in the offshore segment and lower utilization rates.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3203387\" data-linked=\"Helmerich &amp; Payne reiterated Buy at Argus as better positioned than peers\" data-tweet=\"$HP - Helmerich &amp; Payne reiterated Buy at Argus as better positioned than peers https://seekingalpha.com/news/3203387-helmerich-payne-reiterated-buy-argus-better-positioned-peers?source=tweet\" data-url=\"https://seekingalpha.com/news/3203387-helmerich-payne-reiterated-buy-argus-better-positioned-peers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:28 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3203377\" data-ts=\"1471276878\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OBCI\" target=\"_blank\">OBCI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3203377-ocean-bio-chem-up-26-on-q2-income-growth\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ocean Bio-Chem up 26% on Q2 income growth</a></h4><ul><li>Thinly traded nano cap Ocean Bio-Chem (<a href=\"https://seekingalpha.com/symbol/OBCI\" title=\"Ocean Bio-Chem, Inc.\">OBCI</a> <font color=\"green\">+26.4%</font>) heads north on a healthy 70x surge in volume in response to its Q2 results released earlier today. Sales were flat at $8.7M but net income was $657K, up 476%.</li></ul><div class=\"tiny-share-widget\" data-id=\"3203377\" data-linked=\"Ocean Bio-Chem up 26% on Q2 income growth\" data-tweet=\"$OBCI - Ocean Bio-Chem up 26% on Q2 income growth https://seekingalpha.com/news/3203377-ocean-bio-chem-up-26-on-q2-income-growth?source=tweet\" data-url=\"https://seekingalpha.com/news/3203377-ocean-bio-chem-up-26-on-q2-income-growth\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3203379\" data-ts=\"1471276878\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3203379-consumer-goods-top-gainers-losers-of-12-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer Goods - Top Gainers / Losers as of 12:00 pm</a></h4><ul>\n<li>\n<b>Gainers:</b> <a href=\"https://seekingalpha.com/symbol/SORL\" title=\"SORL Auto Parts, Inc.\">SORL</a> <font color=\"green\">+50%</font>. <a href=\"https://seekingalpha.com/symbol/OBCI\" title=\"Ocean Bio-Chem, Inc.\">OBCI</a> <font color=\"green\">+24%</font>. <a href=\"https://seekingalpha.com/symbol/ICON\" title=\"Iconix Brand Group, Inc.\">ICON</a> <font color=\"green\">+10%</font>. <a href=\"https://seekingalpha.com/symbol/GPRO\" title=\"GoPro\">GPRO</a> <font color=\"green\">+9%</font>. <a href=\"https://seekingalpha.com/symbol/WILC\" title=\"G. Willi-Food International, Ltd.\">WILC</a> <font color=\"green\">+9%</font>.</li>\n<li>\n<b>Losers:</b> <a href=\"https://seekingalpha.com/symbol/LBIX-OLD\" title=\"Leading Brands Inc\">LBIX-OLD</a> <font color=\"red\">-15%</font>. <a href=\"https://seekingalpha.com/symbol/VUZI\" title=\"Vuzix Corp\">VUZI</a> <font color=\"red\">-6%</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3203379\" data-linked=\"Consumer Goods - Top Gainers / Losers as of 12:00 pm\" data-tweet=\"$SORL $OBCI $ICON - Consumer Goods - Top Gainers / Losers as of 12:00 pm https://seekingalpha.com/news/3203379-consumer-goods-top-gainers-losers-of-12-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3203379-consumer-goods-top-gainers-losers-of-12-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3203381\" data-ts=\"1471276739\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BAS\" target=\"_blank\">BAS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3203381-basic-energy-delays-18m-bond-interest-payment\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Basic Energy delays $18M bond interest payment</a></h4><ul>     <li>Basic Energy Services (<a href=\"https://seekingalpha.com/symbol/BAS\" title=\"Basic Energy Services, Inc.\">BAS</a> <font color=\"red\">-5%</font>) sinks after saying it will utilize the 30-day grace period on an $18.4M interest payment due today on its 7.75% senior notes  due 2019.</li>     <li>BAS says it is best to use  the grace period to continue to engage in discussions with its secured  and unsecured debtholders regarding strategic alternatives to improve the company's long-term capital structure.</li>     <li>BAS shares continue to bump along all-time lows following <a href=\"https://seekingalpha.com/news/3195198-basic-energy-services-minus-30-percent-time-lows-following-q2-results\" target=\"_blank\">Q2 results</a> and warning that it was seeking refinancing or restructuring options.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3203381\" data-linked=\"Basic Energy delays $18M bond interest payment\" data-tweet=\"$BAS - Basic Energy delays $18M bond interest payment https://seekingalpha.com/news/3203381-basic-energy-delays-18m-bond-interest-payment?source=tweet\" data-url=\"https://seekingalpha.com/news/3203381-basic-energy-delays-18m-bond-interest-payment\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3203374\" data-ts=\"1471276372\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDP\" target=\"_blank\">MDP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3203374-time-incplus-5_9-jana-takes-5m-share-stake\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Time Inc. +5.9% as Jana takes 5M share stake</a></h4><ul>   <li>Time Inc. (TIME) has <font color=\"green\">popped 5.9%</font> today as a <a href=\"https://www.sec.gov/Archives/edgar/data/1159159/000090266416007861/xslForm13F_X01/infotable.xml\" target=\"_blank\">13-F from Jana Partners</a> discloses a new stake of about 5M shares (just over $68M worth at Friday's closing price).</li>    <li>Jana, founded by Barren Rosenstein, sometimes takes activist positions with its investments, including recent runs for change at ConAgra and CSC.</li>    <li>Meanwhile, Time won a labor dispute with the Newspaper Guild of New York, as an administrative law judge said the company was within its rights to declare an impasse in November 2014.</li>    <li>That means employees represented by NewsGuild are governed by their expired agreement, as modified by Time's last, best and final offer.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3203374\" data-linked=\"Time Inc. +5.9% as Jana takes 5M share stake\" data-tweet=\"$MDP - Time Inc. +5.9% as Jana takes 5M share stake https://seekingalpha.com/news/3203374-time-incplus-5_9-jana-takes-5m-share-stake?source=tweet\" data-url=\"https://seekingalpha.com/news/3203374-time-incplus-5_9-jana-takes-5m-share-stake\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:52 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3203365\" data-ts=\"1471274688\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PSG\" target=\"_blank\">PSG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3203365-performance-sports-group-hammered-after-delaying-annual-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Performance Sports Group hammered after delaying annual report</a></h4><ul> <li>Performance Sports Group (NYSE:<a href=\"https://seekingalpha.com/symbol/PSG\" title=\"Performance Sports Group Ltd.\">PSG</a>) craters after delaying the filing of its annual report.</li> <li>The manufacturer of Bauer hockey equipment is <font color=\"red\">down ~64%</font> in trading in both Toronto and New York off concerns of an ongoing internal investigation by the company's audit committee.</li> <li>Recent comments from PSG's management indicate that softness in the baseball and softball business is behind some of the financial pressure.</li> <li>Shares of PSG are at an all-time low of $1.64 at last check.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3203365\" data-linked=\"Performance Sports Group hammered after delaying annual report\" data-tweet=\"$PSG - Performance Sports Group hammered after delaying annual report https://seekingalpha.com/news/3203365-performance-sports-group-hammered-after-delaying-annual-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3203365-performance-sports-group-hammered-after-delaying-annual-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3203352\" data-ts=\"1471274149\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3203352-healthcare-top-gainers-losers-of-11-15\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top Gainers / Losers as of 11:15 am</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/LNTH' title='Lantheus Holdings'>LNTH</a> <font color='green'>+18%</font>. EBIO <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/AAC' title='AAC Holdings, Inc.'>AAC</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/RTTR' title='Ritter Pharmaceuticals'>RTTR</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/MRNS' title='Marinus Pharmaceuticals'>MRNS</a> <font color='green'>+11%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/AUPH' title='Aurinia Pharmaceuticals Inc.'>AUPH</a> <font color='red'>-54%</font>. <a href='https://seekingalpha.com/symbol/MSLI' title='Merus Labs International, Inc.'>MSLI</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/XTLB' title='XTL Biopharmaceuticals Ltd.'>XTLB</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/CLRB' title='Cellectar Biosciences, Inc.'>CLRB</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3203352\" data-linked=\"Healthcare - Top Gainers / Losers as of 11:15 am\" data-tweet=\"$LNTH $SESN $AAC - Healthcare - Top Gainers / Losers as of 11:15 am https://seekingalpha.com/news/3203352-healthcare-top-gainers-losers-of-11-15?source=tweet\" data-url=\"https://seekingalpha.com/news/3203352-healthcare-top-gainers-losers-of-11-15\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:15 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3203361\" data-ts=\"1471274099\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AUPH\" target=\"_blank\">AUPH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3203361-aurinia-pharma-off-57-on-high-death-rate-in-voclosporin-study\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aurinia Pharma off 57% on high death rate in voclosporin study</a></h4><ul>\n<li>Thinly traded nano cap Aurinia Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/AUPH\" title=\"Aurinia Pharmaceuticals Inc.\">AUPH</a> <font color=\"red\">-57%</font>) craters on a whopping 74x surge in volume in response to the shockingly high number of deaths (13) reported in its Phase 2b clinical trial assessing voclosporin in patients with active lupus nephritis (LN). According to the company, the deaths are not related to treatment.</li>\n<li>\n<a href=\"https://slingshotinsights.com/\" target=\"_blank\">Slingshot Insights</a> has created a <a href=\"https://slingshotinsights.com/projects/275\" target=\"_blank\">project </a>for a follow-on interview with an LN expert to discuss the data. This will be an outstanding opportunity for investors to become thoroughly informed on the implications for the company, voclosporin and LN therapies in general. Slingshot hosted an <a href=\"https://slingshotinsights.com/projects/93\" target=\"_blank\">interview </a>with the LN expert prior to the release of the data during which the expert expressed concerns with the program.</li>\n<li>\n<strong>Update</strong>: Slingshot Insights will host an expert interview with Dr. Chaim Putterman, Chief, Division of Rheumatology, Department of Medicine, Albert Einstein College of Medicine and Montefiore Health System tomorrow, August 23, at 3:00 pm ET. <a href=\"https://slingshotinsights.com/projects/275\" target=\"_blank\">Here's the link to sign up</a>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3203361\" data-linked=\"Aurinia Pharma off 57% on high death rate in voclosporin study\" data-tweet=\"$AUPH - Aurinia Pharma off 57% on high death rate in voclosporin study https://seekingalpha.com/news/3203361-aurinia-pharma-off-57-on-high-death-rate-in-voclosporin-study?source=tweet\" data-url=\"https://seekingalpha.com/news/3203361-aurinia-pharma-off-57-on-high-death-rate-in-voclosporin-study\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3203364\" data-ts=\"1471273931\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SVU\" target=\"_blank\">SVU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3203364-supervalu-spikes-after-landing-fresh-market-supplier-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Supervalu spikes after landing The Fresh Market supplier deal</a></h4><ul> <li>Supervalu (NYSE:<a href=\"https://seekingalpha.com/symbol/SVU\" title=\"SUPERVALU Inc.\">SVU</a>) is <font color=\"green\">up 8.7%</font> after starting off the week with a major announcement on a new supply agreement.</li> <li>The Fresh Market is transitioning to using Supervalu as its primary distributor.</li> <li>The switch from The Fresh Market is one of the first obvious signs of the new direction of the grocery chain under private equity ownership.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3203225-supervalu-serve-grocery-wholesaler-fresh-market\" target=\"_blank\">Supervalu to serve as grocery wholesaler for The Fresh Market</a> (Aug. 15)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3203364\" data-linked=\"Supervalu spikes after landing The Fresh Market supplier deal\" data-tweet=\"$SVU - Supervalu spikes after landing The Fresh Market supplier deal https://seekingalpha.com/news/3203364-supervalu-spikes-after-landing-fresh-market-supplier-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3203364-supervalu-spikes-after-landing-fresh-market-supplier-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:12 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3203356\" data-ts=\"1471272292\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EFOI\" target=\"_blank\">EFOI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3203356-energy-focus-downgraded-fbr-capital-following-weak-q2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy Focus downgraded at FBR Capital following weak Q2</a></h4><ul>     <li>Energy Focus (<a href=\"https://seekingalpha.com/symbol/EFOI\" title=\"Energy Focus, Inc.\">EFOI</a> <font color=\"red\">-2.7%</font>) is <a href=\"http://www.streetinsider.com/Analyst+Comments/FBR+Capital+Downgrades+Energy+Focus+%28EFOI%29+to+Market+Perform/11937532.html\" target=\"_blank\">downgraded</a> to Market Perform from Outperform with a $5 price target, cut from $10, at FBR Capital following weak Q2 results marked by a \"temporary\" slowdown of LED sales to the Navy ($3.8M, down 63% Q/Q) not looking so temporary.</li>     <li>FBR says Q2 revenues from the commercial and industrial segment came in at a very disappointing $3.3M, as project time frames were pushed out; despite  highlighting a number of new wins in C&amp;I and a new Naval customer, EFOI's Q3 rev guidance of $8M-$10M  suggests a slow C&amp;I adoption rate, the firm says.</li>     <li>FBR believes EFOI will need to demonstrate at least two to three quarters of substantial revenue growth and regain profitability before it recaptures investor notice.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3203356\" data-linked=\"Energy Focus downgraded at FBR Capital following weak Q2\" data-tweet=\"$EFOI - Energy Focus downgraded at FBR Capital following weak Q2 https://seekingalpha.com/news/3203356-energy-focus-downgraded-fbr-capital-following-weak-q2?source=tweet\" data-url=\"https://seekingalpha.com/news/3203356-energy-focus-downgraded-fbr-capital-following-weak-q2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:44 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3203355\" data-ts=\"1471271741\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JCP\" target=\"_blank\">JCP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3203355-j-c-penney-on-move-ahead-of-analyst-day\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">J.C. Penney on the move ahead of analyst day</a></h4><ul> <li>J.C. Penney (NYSE:<a href='https://seekingalpha.com/symbol/JCP' title='J.C. Penney Company Inc.'>JCP</a>) is <font color='green'>up 5.03%</font> to climb over the $11 level for the first time since March 31.</li> <li>A key point from the company's Q2 report issued last week was the backing of JCP's $1B FY16 EBITDA guidance. This week, J.C. Penney hosts its first analyst day since 2014 during which more details on EBITDA targets are expected to be revealed.</li><li>Over the weekend, several Seeking Alpha contributors dived into J.C. Penney's financials to issue <a href=\"https://seekingalpha.com/symbol/JCP/focus\" target=\"_blank\">new outlooks</a> for investors to digest.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3203355\" data-linked=\"J.C. Penney on the move ahead of analyst day\" data-tweet=\"$JCP - J.C. Penney on the move ahead of analyst day https://seekingalpha.com/news/3203355-j-c-penney-on-move-ahead-of-analyst-day?source=tweet\" data-url=\"https://seekingalpha.com/news/3203355-j-c-penney-on-move-ahead-of-analyst-day\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3203350\" data-ts=\"1471271203\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HPR\" target=\"_blank\">HPR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3203350-bill-barrett-to-resume-dj-basin-drilling\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bill Barrett to resume DJ Basin drilling</a></h4><ul>     <li>Bill Barrett (BBG <font color=\"green\">+4.4%</font>) says it will resume its drilling program in the Denver-Julesburg basin, with up to 12 new wells set to spud by the end of the year.</li>\n<li>BBG says lower well costs and operating expenses, combined with a narrowing DJ Basin oil price differential, will generate a competitive rate-of-return in the current commodity price environment.</li>     <li>BBG projects that its 2016 capex will now be at the  high end of its previously disclosed guidance range of $75M-$100M to account for the additional drilling activity.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3203350\" data-linked=\"Bill Barrett to resume DJ Basin drilling\" data-tweet=\"$HPR - Bill Barrett to resume DJ Basin drilling https://seekingalpha.com/news/3203350-bill-barrett-to-resume-dj-basin-drilling?source=tweet\" data-url=\"https://seekingalpha.com/news/3203350-bill-barrett-to-resume-dj-basin-drilling\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3203348\" data-ts=\"1471271176\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LIVE\" target=\"_blank\">LIVE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3203348-live-venturesplus-14_4-manufacturing-lifts-firm-to-operating-profit\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Live Ventures +14.4% as manufacturing lifts firm to operating profit</a></h4><ul>   <li>Live Ventures (NASDAQ:<a href=\"https://seekingalpha.com/symbol/LIVE\" title=\"Live Ventures\">LIVE</a>) is <font color=\"green\">up 14.4%</font> after <a href=\"https://seekingalpha.com/news/3203283-live-ventures-reports-fq3-results\" target=\"_blank\">fiscal Q3 results</a> where it swung to an operating profit as revenues grew by six times Y/Y.</li>    <li>Revenues of $19.99M compared to a year-ago $2.94M, with the addition of the company's manufacturing business contributing nearly all of that ($19.2M). Excluding the manufacturing business, revenues fell 74%.</li>    <li>Revenue by segment: Manufacturing, $19.24M (new); Marketplace platform, $508,099 (down 80.2%); Services, 243,245 (down 35%).</li>    <li>The company wrote down inventory tied to its Modern Everyday business in the amount of $0.8M, and excluding that and a one-time gain of $12.2M, EPS was $0.11 vs. the headline number of $0.79.</li>     </ul><div class=\"tiny-share-widget\" data-id=\"3203348\" data-linked=\"Live Ventures +14.4% as manufacturing lifts firm to operating profit\" data-tweet=\"$LIVE - Live Ventures +14.4% as manufacturing lifts firm to operating profit https://seekingalpha.com/news/3203348-live-venturesplus-14_4-manufacturing-lifts-firm-to-operating-profit?source=tweet\" data-url=\"https://seekingalpha.com/news/3203348-live-venturesplus-14_4-manufacturing-lifts-firm-to-operating-profit\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:26 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3203334\" data-ts=\"1471269564\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNBR\" target=\"_blank\">SNBR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3203334-select-comfort-rallies-after-piper-upgrades\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Select Comfort rallies after Piper upgrades</a></h4><ul> <li>Select Comfort (SCSS <font color=\"green\">+7.3%</font>) is higher after Piper Jaffray upgrades the retail stock to Overweight from Neutral.</li> <li>The investment firm bumps its price target on SCSS 35% higher to $31.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3203334\" data-linked=\"Select Comfort rallies after Piper upgrades\" data-tweet=\"$SNBR - Select Comfort rallies after Piper upgrades https://seekingalpha.com/news/3203334-select-comfort-rallies-after-piper-upgrades?source=tweet\" data-url=\"https://seekingalpha.com/news/3203334-select-comfort-rallies-after-piper-upgrades\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3203319\" data-ts=\"1471267585\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WIMHF\" target=\"_blank\">WIMHF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3203319-william-hill-rejects-new-buyout-offer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">William Hill rejects new buyout offer</a></h4><ul>     <li>William Hill (<a href='https://seekingalpha.com/symbol/WIMHF' title='William Hill Plc'>OTCPK:WIMHF</a>) <a href=\"http://uk.reuters.com/article/uk-william-hill-m-a-888-holdings-rank-gr-idUKKCN10Q0G8\" target=\"_blank\">turned away</a> a new offer from 888 Holdings (<a href='https://seekingalpha.com/symbol/EIHDF' title='888 Holdings plc.'>OTCPK:EIHDF</a>) and Rank Group (<a href='https://seekingalpha.com/symbol/RANKF' title='Rank Group &#40;THE&#41; p.l.c.'>OTCPK:RANKF</a>).</li>     <li>The U.K. company says the deal valued at &pound;3.16B wasn't high enough to merit further engagement.</li>     <li>Shares of William Hill are <font color='red'>down 3.48%</font> in London trading.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3203319\" data-linked=\"William Hill rejects new buyout offer\" data-tweet=\"$WIMHF $WIMHF $EIHDF - William Hill rejects new buyout offer https://seekingalpha.com/news/3203319-william-hill-rejects-new-buyout-offer?source=tweet\" data-url=\"https://seekingalpha.com/news/3203319-william-hill-rejects-new-buyout-offer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:26 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3203310\" data-ts=\"1471266732\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3203310-premarket-gainers-losers-of-9-10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers / Losers as of 9:10 am</a></h4><ul> <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/SORL' title='SORL Auto Parts, Inc.'>SORL</a> <font color='green'>+42%</font>. <a href='https://seekingalpha.com/symbol/KGJI' title='KINGOLD JEWELRY'>KGJI</a> <font color='green'>+32%</font>. <a href='https://seekingalpha.com/symbol/LIVE' title='Live Ventures'>LIVE</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/CLSN' title='Celsion Corporation'>CLSN</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/OCUL' title='Ocular Therapeutix'>OCUL</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/NBY' title='NovaBay Pharmaceuticals, Inc.'>NBY</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/ACIA' title='Acacia Communications'>ACIA</a> <font color='green'>+6%</font>.</li> <li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/AUPH' title='Aurinia Pharmaceuticals Inc.'>AUPH</a> <font color='red'>-48%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3203310\" data-linked=\"Premarket Gainers / Losers as of 9:10 am\" data-tweet=\"$SORL $KGJI $LIVE - Premarket Gainers / Losers as of 9:10 am https://seekingalpha.com/news/3203310-premarket-gainers-losers-of-9-10?source=tweet\" data-url=\"https://seekingalpha.com/news/3203310-premarket-gainers-losers-of-9-10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3203308\" data-ts=\"1471266642\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AEO\" target=\"_blank\">AEO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3203308-american-eagle-outfitters-tracks-higher-after-deutsche-bank-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">American Eagle Outfitters tracks higher after Deutsche Bank upgrade</a></h4><ul> <li>American Eagles Outfitters (NYSE:<a href=\"https://seekingalpha.com/symbol/AEO\" title=\"American Eagle Outfitters, Inc.\">AEO</a>) is on the move after Deutsche Bank <a href=\"http://www.streetinsider.com/Analyst+Comments/Deutsche+Bank+Upgrades+American+Eagle+Outfitters+%28AEO%29+to+Buy/11937642.html\" target=\"_blank\">boosts</a> its rating to Buy from Hold.</li> <li>Despite the recent AEO rally, Deutsche Bank thinks there is still enough runway to warrant a bullish stance after a \"solid\" start to the Back to School season for the retailer.</li>\n<li>DB lifts its price target to $22 from $17.</li> <li>AEO <font color=\"green\">+3.54%</font> premarket to $19.60.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3203308\" data-linked=\"American Eagle Outfitters tracks higher after Deutsche Bank upgrade\" data-tweet=\"$AEO - American Eagle Outfitters tracks higher after Deutsche Bank upgrade https://seekingalpha.com/news/3203308-american-eagle-outfitters-tracks-higher-after-deutsche-bank-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3203308-american-eagle-outfitters-tracks-higher-after-deutsche-bank-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:10 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3203307\" data-ts=\"1471266280\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLSN\" target=\"_blank\">CLSN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3203307-celsion-beats-0_02-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Celsion beats by $0.02, beats on revenue</a></h4><ul>\n<li>Celsion (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CLSN\" title=\"Celsion Corporation\">CLSN</a>): Q2 EPS of -$0.19 <font color=\"green\">beats by $0.02</font>.</li>\n<li>Revenue of $0.13M (flat Y/Y) <font color=\"green\">beats by $0.05M</font>.</li>\n<li>Shares <font color=\"green\">+7.5%</font> PM.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3203307\" data-linked=\"Celsion beats by $0.02, beats on revenue\" data-tweet=\"$CLSN - Celsion beats by $0.02, beats on revenue https://seekingalpha.com/news/3203307-celsion-beats-0_02-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3203307-celsion-beats-0_02-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:04 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3203305\" data-ts=\"1471266132\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GWR\" target=\"_blank\">GWR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3203305-genesee-wyoming-acquires-providence-and-worcester-railroad-company\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Genesee &amp; Wyoming acquires Providence and Worcester Railroad Company</a></h4><ul> <li>Genesee &amp; Wyoming (NYSE:<a href=\"https://seekingalpha.com/symbol/GWR\" title=\"Genesee &amp; Wyoming, Inc.\">GWR</a>) announced that it acquired Providence and Worcester Railroad Company (NASDAQ:<a href=\"https://seekingalpha.com/symbol/PWX\" title=\"Providence and Worcester Railroad Company\">PWX</a>) for $25.00 per share.</li>\n<li>The $126M deal  is expected to close following the receipt of P&amp;W shareholder approval       in Q4.</li>           <li>Upon approval by the Surface Transportation Board, P&amp;W would be       managed as part of G&amp;W\u2019s Northeast Region.</li>\n<li>The company expects the acquisition to unlock significant cost savings through       overhead, operational, and long-term network efficiencies as well as to       generate significant new commercial opportunities.</li>     <li>G&amp;W expects P&amp;W will require approximately $3M of annual capital       expenditures and have depreciation and amortization expense of       approximately $3M.</li>\n<li>PWX <font color=\"green\">+49.20%</font> premarket to $24.32.</li>     </ul><div class=\"tiny-share-widget\" data-id=\"3203305\" data-linked=\"Genesee &amp; Wyoming acquires Providence and Worcester Railroad Company\" data-tweet=\"$GWR $GWR $PWX - Genesee &amp; Wyoming acquires Providence and Worcester Railroad Company https://seekingalpha.com/news/3203305-genesee-wyoming-acquires-providence-and-worcester-railroad-company?source=tweet\" data-url=\"https://seekingalpha.com/news/3203305-genesee-wyoming-acquires-providence-and-worcester-railroad-company\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:02 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3203302\" data-ts=\"1471265910\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RSLS\" target=\"_blank\">RSLS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3203302-two-year-data-show-enteromedics-maestro-device-helps-obese-patients-lose-weight-shares-up-12\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Two-year data show EnteroMedics&#39; Maestro device helps obese patients lose weight; shares up 12% premarket</a></h4><ul>\n<li>Penny stock EnteroMedics (ETRM) is up <font color=\"green\">12%</font> premarket on increased volume in response to its <a href=\"http://www.prnewswire.com/news-releases/enteromedics-announces-publication-of-24-month-recharge-clinical-study-data-in-obesity-surgery-300313199.html\" target=\"_blank\">announcement </a>that 24-month data from its Phase 3 <a href=\"https://clinicaltrials.gov/ct2/show/NCT01327976?term=enteromedics&amp;rank=1\" target=\"_blank\">ReCharge</a> clinical trial has been <a href=\"http://link.springer.com/article/10.1007/s11695-016-2325-7\" target=\"_blank\">published </a>in the journal <em>Obesity Surgery</em>. The study assessed the efficacy of its Maestro Rechargeable System in reducing weight in obese patients. The FDA approved it in January 2015 for weight loss treatment in adult patients who have been unable to lose weight with a weight loss program and who have a body mass index (BMI) of 35 to 45 with at least one other obesity-related co-morbidity (hypertension, type 2 diabetes, high cholesterol).</li>\n<li>In 123 subjects who presented in their 24-month visit, the mean excess weight loss was 21% and the mean percent total weight loss (TWL) was 8%. In patients treated with sham control who had not yet crossed over to Maestro, the values were 4% and 1%, respectively. For comparison purposes, published studies on bariatric procedures (i.e., gastric banding) showed 6% TWL at the same time point. Maestro patients also reported improvements in quality-of-life measures and reductions in hunger.</li>\n<li>\n<a href=\"http://www.enteromedics.com/usa/vbloc_maestro_system.asp\" target=\"_blank\">Maestro</a>, a pacemaker-like device, delivers <a href=\"http://www.enteromedics.com/international/about_vbloc_therapy.asp\" target=\"_blank\">VBLOC </a>vagal nerve blocking therapy via electrodes that are surgically implanted subcutaneously in the abdomen. The electrodes are placed in contact with the trunks of the vagus nerves just above the junction between the esophagus and the stomach. The device intermittently blocks vagal nerve signals throughout the patient's waking hours.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/2222146-fda-clears-new-obesity-device\" target=\"_blank\">FDA clears new obesity device</a> (Jan. 14, 2015)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3203302\" data-linked=\"Two-year data show EnteroMedics&#39; Maestro device helps obese patients lose weight; shares up 12% premarket\" data-tweet=\"$RSLS - Two-year data show EnteroMedics&#39; Maestro device helps obese patients lose weight; shares up 12% premarket https://seekingalpha.com/news/3203302-two-year-data-show-enteromedics-maestro-device-helps-obese-patients-lose-weight-shares-up-12?source=tweet\" data-url=\"https://seekingalpha.com/news/3203302-two-year-data-show-enteromedics-maestro-device-helps-obese-patients-lose-weight-shares-up-12\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3203283\" data-ts=\"1471264335\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LIVE\" target=\"_blank\">LIVE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3203283-live-ventures-reports-fq3-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Live Ventures reports FQ3 results</a></h4><ul>\n<li>Live Ventures (NASDAQ:<a href=\"https://seekingalpha.com/symbol/LIVE\" title=\"Live Ventures\">LIVE</a>): FQ3 EPS of $0.11</li>\n<li>Revenue of $20M (+580.3% Y/Y)</li>\n<li>Shares <font color=\"green\">+19.6%</font> PM.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3203283\" data-linked=\"Live Ventures reports FQ3 results\" data-tweet=\"$LIVE - Live Ventures reports FQ3 results https://seekingalpha.com/news/3203283-live-ventures-reports-fq3-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3203283-live-ventures-reports-fq3-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:32 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3203262\" data-ts=\"1471262858\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACRX\" target=\"_blank\">ACRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3203262-acelrx-pharmas-pain-med-arxminus-04-successful-in-late-stage-study-in-emergency-room-setting\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AcelRx Pharma&#39;s pain med ARX-04 successful in late-stage study in emergency room setting; shares up 12% premarket</a></h4><ul>\n<li>Thinly traded micro cap AcelRx Pharmaceuticals (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ACRX\" title=\"AcelRx Pharmaceuticals, Inc.\">ACRX</a>) is up <font color=\"green\">12%</font> premarket on light volume in response to its <a href=\"http://www.prnewswire.com/news-releases/acelrx-pharmaceuticals-arx-04-phase-3-trial-met-its-primary-endpoint-reduced-pain-intensity-in-er-patients-with-moderate-to-severe-acute-pain-300312758.html\" target=\"_blank\">announcement </a>of positive results in a Phase 3 clinical trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT02447848\" target=\"_blank\">SAP302</a>, assessing product candidate ARX-04 (sufentanil sublingual tablet, 30 mcg) in 76 patients presented in the emergency room with moderate-to-severe acute pain associated with trauma or injury. The data are being <a href=\"https://www.sec.gov/Archives/edgar/data/1427925/000143774916037360/ex99-1.htm\" target=\"_blank\">presented </a>today at the 2016 Military Health System Research Symposium in Kissimmee, FL.</li>\n<li>The initial phase of the study enrolled 40 patients who received a single dose of ARX-04. The extension phase enrolled 36 patients who were eligible to receive up to four doses of ARX-04, administered hourly as needed for pain.</li>\n<li>Subjects treated with a single dose of ARX-04 experienced a reduction in pain intensity of 33% at one hour as measured by a 0-10 rating scale (mean reduction of 2.7 from baseline of 8.1). Patients in the extension phase experienced a 38% reduction in pain from baseline (mean reduction of 3.1 from baseline of 8.1). 75% of the extension phase subjects achieved sufficient pain relief with a single dose of ARX-04 while only 8% received morphine in addition to ARX-04.</li>\n<li>No adverse events (AEs) were observed in 79% of patients. The most common AEs reported were nausea (9%), drowsiness (5%) and vomiting (4%).</li>\n<li>\n<a href=\"http://www.acelrx.com/pipeline/arx-04.html\" target=\"_blank\">ARX-04</a> consists of 30 mcg tablets of <a href=\"https://en.wikipedia.org/wiki/Sufentanil\" target=\"_blank\">sufentanil</a> (synthetic opioid five to ten times as potent as fentanyl) delivered as often as once per hour sublingually (under the tongue) via a disposable, pre-filled, single-dose applicator. The military is interested in the product for use in the field since wounded personnel may not have ready access to injectable pain medication.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3203262\" data-linked=\"AcelRx Pharma&#39;s pain med ARX-04 successful in late-stage study in emergency room setting; shares up 12% premarket\" data-tweet=\"$ACRX - AcelRx Pharma&#39;s pain med ARX-04 successful in late-stage study in emergency room setting; shares up 12% premarket https://seekingalpha.com/news/3203262-acelrx-pharmas-pain-med-arxminus-04-successful-in-late-stage-study-in-emergency-room-setting?source=tweet\" data-url=\"https://seekingalpha.com/news/3203262-acelrx-pharmas-pain-med-arxminus-04-successful-in-late-stage-study-in-emergency-room-setting\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:07 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3203256\" data-ts=\"1471262557\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SYY\" target=\"_blank\">SYY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3203256-sysco-beats-0_03-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SYSCO beats by $0.03, misses on revenue</a></h4><ul>\n<li>SYSCO (NYSE:<a href=\"https://seekingalpha.com/symbol/SYY\" title=\"Sysco Corporation\">SYY</a>): Q2 EPS of $0.64 <font color=\"green\">beats by $0.03</font>.</li>\n<li>Revenue of $13.6B (+9.7% Y/Y) <font color=\"red\">misses by $80M</font>.</li>\n<li>Shares <font color=\"green\">+4.6%</font> PM.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3203256\" data-linked=\"SYSCO beats by $0.03, misses on revenue\" data-tweet=\"$SYY - SYSCO beats by $0.03, misses on revenue https://seekingalpha.com/news/3203256-sysco-beats-0_03-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3203256-sysco-beats-0_03-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3203240\" data-ts=\"1471260660\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AUPH\" target=\"_blank\">AUPH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3203240-aurinia-pharmas-lead-product-candidate-successful-in-mid-stage-stage-study-shares-jump-17\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aurinia Pharma&#39;s lead product candidate successful in mid-stage stage study; shares jump 17% premarket</a></h4><ul>\n<li>Thinly traded micro cap Aurinia Pharmaceuticals (NASDAQ:<a href=\"https://seekingalpha.com/symbol/AUPH\" title=\"Aurinia Pharmaceuticals Inc.\">AUPH</a>) perks up <font color=\"green\">17% </font>premarket on modest volume in response to its announcement that its Phase 2b clinical trial, AURA-LV, assessing lead product candidate, Fast Track-tagged voclosporin, met its primary efficacy endpoint in patients with active lupus nephritis (LN), an inflammation of the kidney caused by the autoimmune disorder systemic lupus erythematosus (SLE).</li>\n<li>AURA-LV compared the efficacy of voclosporin added to current standard-of-care therapy mycophenolate mofetil [Roche's (<a href=\"https://seekingalpha.com/symbol/RHHBY\" title=\"Roche Holding Ltd ADR\">OTCQX:RHHBY</a>) <a href=\"http://www.cellcept.com/patient\" target=\"_blank\">CellCept</a>] against placebo plus CellCept in achieving complete remission in 265 patients with active LN. Participants were randomized to receive one of two dosages of voclosporin (23.7 mg or 39.5 mg twice daily) or placebo. All subjects received CellCept and oral corticosteroids as background therapy. The primary endpoint was the number of patients who achieved CR at week 24, defined as a protein/creatinine ratio of no more than 0.5 mg/mg in addition to normal stable renal function.</li>\n<li>32.6% of patients in the low dose voclosporin arm, 27.3% in the high dose arm and 19.3% in the control arm achieved CR (p=0.045). Patients treated with voclosporin were twice as likely to achieve CR compared to placebo (odds ratio = 2.03).</li>\n<li>Volclosporin was well-tolerated with no unexpected safety signals observed.</li>\n<li>\n<a href=\"http://www.auriniapharma.com/dnn/ProductsInDevelopment/Voclosporin/WhatisVoclosporin.aspx\" target=\"_blank\">Voclosporin </a>suppresses the immune system by inhibiting an enzyme called <a href=\"https://en.wikipedia.org/wiki/Calcineurin\" target=\"_blank\">calcineurin</a>, which activates T cells. Its value proposition is similar effectiveness to other calcineurin inhibitors (cyclosporin and tacrolimus) without the deleterious side effects.</li>\n<li>The company intends to meet with the FDA in Q4 to discuss the results and clarify a regulatory path to approval. Further analyses of the data will be released later this year and will be submitted for presentation at a future medical conference. The study will continue through 48 weeks. These data will be announced in early 2017.</li>\n<li>Management will host a conference call this morning at 8:00 am ET.</li>\n<li>Read Now <a href=\"https://seekingalpha.com/article/3998155-aurinia-pharmaceuticals-phase-2b-trial-results-will-game-changer-trial-results-imminent\" target=\"_blank\">Aurinia Pharmaceuticals' Phase 2B Trial Results Will Be A Game Changer: Trial Results Are Imminent</a>\n</li>\n<li>\n<strong>Update</strong>: Shares reversed and are now down <font color=\"red\">48%</font>. The culprit is the disclosure that there were 13 deaths in the trial, two in the low-dose voclosporin arm, 10 in the high-dose arm and one in the control arm, although none were determined to be related to treatment.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3203240\" data-linked=\"Aurinia Pharma&#39;s lead product candidate successful in mid-stage stage study; shares jump 17% premarket\" data-tweet=\"$AUPH $AUPH $RHHBY - Aurinia Pharma&#39;s lead product candidate successful in mid-stage stage study; shares jump 17% premarket https://seekingalpha.com/news/3203240-aurinia-pharmas-lead-product-candidate-successful-in-mid-stage-stage-study-shares-jump-17?source=tweet\" data-url=\"https://seekingalpha.com/news/3203240-aurinia-pharmas-lead-product-candidate-successful-in-mid-stage-stage-study-shares-jump-17\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":50,"message":null,"success":true,"today":{"start":1576990800,"end":1577077199,"str":"Sunday, December 22, 2019"},"yesterday":{"start":1576904400,"end":1576990799}}